D. Carreon

Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.

Steven G. Potkin, R. Bera, Bala Gulasekaram et al. · PubMed · 1994 · 208 citations

Plasma Concentrations, Neuropsychology, Psychiatry +14

Therapeutic Effects of Individualized Alpha Frequency Transcranial Magnetic Stimulation ( TMS) on the Negative Symptoms of Schizophrenia

Yi Jin, Steven G. Potkin, Aaron S. Kemp et al. · Schizophrenia Bulletin · 2005 · 140 citations · Full text

Neuropsychology, Therapeutic Effects, Neuropsychiatry +20

D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine

Steven G. Potkin, Vincenzo S. Basile, Yi Jin et al. · Molecular Psychiatry · 2003 · 114 citations

Functional Selectivity, Medicine, Schizophrenia +9

Phase <scp>IA</scp>/<scp>II</scp>, multicentre, open‐label study of the <scp>CD</scp>40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐<scp>H</scp>odgkin or <scp>H</scp>odgkin lymphoma

Michelle A. Fanale, Sarit Assouline, John Kuruvilla et al. · British Journal of Haematology · 2013 · 75 citations · Full text

Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial

Aditya Bardia, Marina Parton, Sherko Kümmel et al. · Journal of Clinical Oncology · 2018 · 73 citations · Full text